April 28th 2025
The Regeneron SVP details the company’s approach to reaching oncology patients across the planet.
April 25th 2025
The chaotic tariff situation is forcing pharma companies to prepare for multiple outcomes.
While supply chain interruptions are a strong possibility, the tariffs also provide the industry with a chance to improve certain conditions.
April 17th 2025
Four tips for midsized companies when entering new global markets.
March 21st 2025
The pharmaceutical company had previously been subjected to a 2-year suspension.
Recipes for Success in India and China
Dr Frank Floether provides a no-nonsense guide to securing a successful alliance in Asia.
EU Generic Applications Down
August 20, 2010.
Finalists for Biotechnica Award Named
13 August, 2010.
EGA Talks Biosimilars
The European Generic Medicines Association's Director for Scientific Affairs, Suzette Cox, talks to us about the environment for biosimilars.
Choosing Your General Manager for China
With substantial growth predicted in the life sciences industry, appointing the right General Manager (GM) in China has never been more important. But where should he or she come from?
Strategies for Emerging Markets: Seven Keys to the Kingdom
It's back to the future in Pharm Exec's second-annual review of industry prospects in the IMS "Pharmerging 17"
Sanofi Fights FDA Approval of Generic Lovenox
August 2, 2010.
Servier Back in EC's Anticompetitive Behaviour Spotlight
August 01, 2010. French pharma giant accused of providing "misleading" and "incorrect" information.
China: Behind the Screen
To shed some light on China's potential, Pharm Exec sat down with Peter Young, President and Managing Partner of Young & Partners, who recently met with government and industry officials to review the investment and M&A climate for medicines.
Convention Targets Counterfeiting
July 23, 2010.
Europe Earmarks €6bn for Research and Innovation
Drug Safety Experts Call For New Openness
UK Coalition Government Unveils Radical NHS Plans
July 14, 2010.
Lilly Moves into Enzyme Replacement Therapy
July 10, 2010.
Cut Your IT Costs WIth Shared Services
Kamal Biswas outlines some techniques for the successful design and implementation of an IT shared services model in pharma.
Response to the Fiscal Crisis: The Valuing Conversation
As Europe sets the pace in slashing drug prices to meet austerity goals industry is seeking fresh ways to control the fallout. Will more dialogue be enough?
Are Your Drugs Taking Too Long to Get to Market?
Richard Watts and Chris Hart highlight some of the issues companies need to tackle to speed up their drug development process.
Emerging Markets Under Anti-Corruption Microscope
As they build market share, companies need a plan to limit exposure to steep fines and executive prosecutions.
Actavis Appoints Generics Veteran as New CEO
June 29, 2010.
'Fairness', Risk Sharing and the European Price Cuts
As pharma companies protest decisions to cut drug prices in Greece, Spain and Germany, the question of fair play is brought in sharp focus. But, says Jacky Law, even-handedness in drug pricing works both ways.
Almac's Sir Allen McClay Receives Posthumous Award
June 23, 2010.
First-Call IMI Projects "Up and Running"
June 14, 2010.
BIO 2010: Potemkin Pavillions and the Power of NICE
Can Combating the Counterfeiters Hurt Pharma Too?
The broadening of the EU debate on counterfeit medicines may actually have some negative effects on Big Pharma, argues Reflector.
What Do You Think of Pharm Exec Europe?
Tell us and win an iPod Touch!
European Austerity Measures Hit Drug Prices
June 4, 2010.
How to Start Your Social Media Strategy
It is now the job of the pharma marketer to get people talking and to listen to what they are saying. Jody Ball offers advice on making that transition.
Irish Pharma Backs 'Innovation Island'
May 24, 2010.
Patent Cliff Pushes Pharma to the Brink
Record Year for Doctors Online
May 7, 2010.